Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
The Salesforce Delivery Lifecycle Is Broken: New Research
-
Griffin Hoffmann Joins Andover Real Estate Partners as Principal, Head of Acquisitions
-
OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies
-
Biometric Identity and Authentication Provider BIO-key to host Q1’26 Investor Webcast Monday, May 18th at 10am ET
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 11 05 2026] - (CGWL)
-
FX Junction Releases Report on Top 5 Cases of Social Media Impact on Stock Markets
-
Diana Shipping Inc. Launches Campaign Website in Connection with Effort to Unlock Immediate Value at Genco Shipping & Trading
-
Diana Shipping Inc. Launches Campaign Website in Connection with Effort to Unlock Immediate Value at Genco Shipping & Trading
-
Crypto News Today:AI GPU RENTAL Enables AI-Driven Infrastructure Access Bitcoin Price Expected to Reach $310,000
-
ZenaTech Targets Gulf State Defense Markets with Lviv-Based Phoenix Aero Counter-UAS and Interceptor Drone Production
-
MiNK Therapeutics Presents Clinical Evidence That a Single, Off-the-Shelf, iNKT Cell Product Drives Context-Dependent Immune Responses at ASGCT 2026
-
Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics
-
Sylogist Announces First Quarter 2026 Results
-
Nayax Reports First Quarter 2026 Results
-
SAB BIO Reports Q1 2026 Financial Results and Recent Business Highlights
-
Aveanna to Participate at the William Blair 46th Annual Growth Stock Conference
-
Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates
-
Vireo Growth Inc. Announces First Quarter 2026 Results
-
NIOB Seigneurie Step-out Drilling Confirms Pegmatite System Extends Laterally Over 1.5 kilometres
-
BridgeBio Submits NDA to FDA for Encaleret for Individuals Living with ADH1
-
Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates
-
Zevra Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference
-
Growth + Income Emerges as a Category: TappAlpha Crosses $500M AUM, Doubling in Four Months
-
Sagimet Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates
-
Compass Therapeutics to Participate in Upcoming May Investor Events
-
Harvard Bioscience Announces First Quarter 2026 Financial Results
-
BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients
-
Aging Renters Emerge as a Strategic Growth Opportunity for Insurance Providers, New TransUnion Report Finds
-
POET Technologies Announces Appointment of Sandeep Kumar as Chief Operating Officer
-
OVIOS x Studio F. A. Porsche Debuts AERO EVO on the Nasdaq Tower in Times Square
-
Hub Group Files Form 12b-25 and Provides First Quarter 2026 Business Update
-
Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma
-
Arvinas Reports First Quarter 2026 Financial Results and Provides Corporate Update
-
Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
-
NeurAxis Reports Record First Quarter 2026 Financial Results Driven by 80% Year Over Year Revenue Growth
-
CorVel Corporation to Host Live Earnings Release Webcast
-
Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)
-
Cartesian Therapeutics to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
-
Creative Realities, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Information
-
Prelude Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
-
Bitdeer Announces April 2026 Production and Operations Update
-
Parex Resources Positioned to Become Colombia’s Largest Independent Oil & Gas Producer, Provides Step-Change Guidance, Reports Q1 2026 Results, and Declares Q2 2026 Dividend
-
C4 Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
-
Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
-
George Weston Limited Reports First Quarter 2026 Results
-
MADD Canada Calls for Anti-Impaired Driving Technology as Global Safety Leaders Meet in Toronto
-
Mediacom Advances Its DOCSIS 4.0 Network Upgrades Plans With AOI Quantum Bandwidth
-
Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference
-
American Bus Association Sues New York City Over Discriminatory Idling Enforcement That Threatens Interstate Transportation and the City’s Economy
-
Legacy Cremation Services Brazenly Violating Federal Court Order

